The cell-free DNA (cfDNA) blood collection tube market is ripe with opportunities driven by the rise in lifestyle-related ...

A new blood test measures cell-free DNA to detect ALS early and distinguish it from other neurological disorders.

A new study may finally change how amyotrophic lateral sclerosis (ALS) is diagnosed. Scientists from UCLA Health and the ...

Dear Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? Dear M.N.: When screening patients for ...

Fetuses at high risk for cystic fibrosis may be detected by screening of pregnant mothers using reflex to cell-free DNA analysis.

Researchers developed a cell-free DNA blood test that accurately distinguishes ALS from other neurological diseases and tracks progression.

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

Natera Inc. (($NTRA)) announced an update on their ongoing clinical study. Study Overview: Natera Inc. is conducting a study titled ‘EXpanding ...

Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...

(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for ...